Using asthma mouse models, it was shown that eosinophilic inflammation is significantly decreased following allergic stimuli in animals subjected to treatments with recombinant IL1RL1 or antibodies directed against the membrane-anchored protein [33, 34]. Here, IL1RL1 is linked to asthma.